Retour sur lavenir.net
   UMICORE 17.600 € (-0,17 %)     EVS BROADC.EQUIPM. 36.550 € (+0,27 %)     SEQUANA MEDICAL 0.522 € (+5,14 %)     XIOR 27.650 € (-0,54 %)     GBL 80.700 € (-0,92 %)     SOFINA 226.000 € (-0,35 %)     BARCO 9.425 € (-3,23 %)     AEDIFICA 73.600 € (-0,81 %)     MELEXIS 65.300 € (+2,75 %)     ACKERMANS V.HAAREN 279.200 € (-0,64 %)     AB INBEV 62.580 € (-2,31 %)     ELIA GROUP 137.900 € (-0,93 %)     AGEAS 68.600 € (+0,88 %)     ARGENX SE 686.400 € (-3,00 %)     KBC ANCORA 78.900 € (-1,00 %)     KINEPOLIS GROUP 30.400 € (+0,66 %)     BANQUP GROUP 2.740 € (+3,79 %)     WERELDHAVE BELGIUM 53.600 € (-1,83 %)     SOLVAY 27.360 € (-1,72 %)     UNIFIEDPOST GROUP 2.740 € (+3,79 %)     BEKAERT 41.850 € (+0,72 %)     HOME INVEST BE. 19.160 € (-1,84 %)     AZELIS GROUP 10.360 € (+0,78 %)     CIE BOIS SAUVAGE 323.000 € (-0,31 %)     CENERGY 21.160 € (+0,19 %)     DEME GROUP 184.800 € (-0,11 %)     WDP 23.880 € (-1,08 %)     BREDERODE 103.600 € (+0,39 %)     CARE PROPERTY INV. 12.820 € (-0,77 %)     SHURGARD 27.850 € (-0,36 %)     OPTION 6.760 € (-3,43 %)     LOTUS BAKERIES 9 940.000 € (-0,30 %)     D'IETEREN GROUP 182.700 € (-1,14 %)     AGFA-GEVAERT 0.487 € (-0,51 %)     VIOHALCO 14.500 € (0,00 %)     GIMV 48.650 € (+0,41 %)     ECONOCOM GROUP 1.485 € (0,00 %)     KBC 117.750 € (-0,63 %)     COLRUYT 33.140 € (+0,42 %)     FAGRON 23.800 € (-2,26 %)     TESSENDERLO 21.100 € (-0,24 %)     VAN DE VELDE 32.500 € (+0,31 %)     UCB 247.100 € (-4,59 %)     ASCENCIO 50.000 € (-0,79 %)     FLUXYS BELGIUM D 21.500 € (+0,94 %)     JENSEN-GROUP 71.000 € (-0,84 %)     TUBIZE-FIN 214.800 € (-3,33 %)     RECTICEL 10.020 € (-0,99 %)     BPOST 1.882 € (-0,84 %)     CMB.TECH 11.260 € (-1,05 %)     VASTNED 30.100 € (+0,17 %)     BIOTALYS 2.285 € (-1,51 %)     IMMOBEL 21.600 € (+0,93 %)     DECEUNINCK 2.175 € (+0,69 %)     ONTEX GROUP 3.040 € (-3,34 %)     MONTEA 72.200 € (-0,96 %)     RETAIL ESTATES 69.800 € (-2,10 %)     IBA 14.400 € (-0,96 %)     TITAN S.A. 46.740 € (-1,72 %)     ONWARD MEDICAL 2.905 € (-2,02 %)  
   ABEO 8.060 € (+1,51 %)     SAFRAN 282.400 € (-6,80 %)     HOPIUM 0.008 € (-2,44 %)     BE SEMICONDUCTOR 227.900 € (+0,40 %)     GENFIT 8.900 € (-2,41 %)     SHELL PLC 37.695 € (+0,24 %)     STMICROELECTRONICS 37.610 € (+0,90 %)     EXOR NV 70.000 € (-0,28 %)     SANOFI 81.020 € (-1,23 %)     LVMH 486.000 € (-0,93 %)     UMG 20.080 € (-1,47 %)     KERING 243.200 € (-2,01 %)     MR BRICOLAGE 4.670 € (-1,68 %)     CARREFOUR 16.710 € (-0,54 %)     AIRBUS 170.520 € (-1,54 %)     AXA 42.420 € (-0,07 %)     FLEURY MICHON 22.300 € (0,00 %)     AALBERTS NV 31.440 € (-0,69 %)     TIKEHAU CAPITAL 19.200 € (-2,34 %)     FASTNED 29.800 € (+5,11 %)     JCDECAUX 19.230 € (-3,42 %)     ATOS 36.240 € (-2,74 %)     NANOBIOTIX 26.340 € (-5,05 %)     SARTORIUS STED BIO 188.500 € (+0,96 %)     LEGRAND 147.750 € (-0,54 %)     SOITEC 100.750 € (+0,75 %)     ARKEMA 61.600 € (-0,65 %)     CSG 21.040 € (-0,82 %)     ACCOR 44.340 € (-2,27 %)     UNIBAIL-RODAMCO-WE 104.750 € (-0,62 %)     AIR FRANCE -KLM 9.896 € (-3,50 %)     BIOMERIEUX 90.600 € (+0,50 %)     ADOCIA 5.720 € (+16,83 %)     ABN AMRO BANK N.V. 30.200 € (+0,33 %)     MANITOU BF 21.750 € (+1,64 %)     BOLLORE 5.080 € (+1,09 %)     CRCAM ILLE-VIL.CCI 116.120 € (+0,66 %)     CTP 16.100 € (-1,35 %)     GROUPE OKWIND 1.200 € (+36,36 %)     BENETEAU 7.100 € (-1,11 %)     ABIVAX 98.000 € (-2,58 %)     BNP PARIBAS ACT.A 92.140 € (-0,50 %)     BASIC-FIT 31.460 € (-0,57 %)     CIECHARGEURSINVEST 8.500 € (0,00 %)     THALES 247.700 € (-5,92 %)     Coca-ColaEuropacif 82.100 € (-1,20 %)     SPIE 46.460 € (-1,27 %)     TECHNIP ENERGIES 39.420 € (-0,15 %)     SCHNEIDER ELECTRIC 272.100 € (-0,55 %)     ING GROEP N.V. 24.495 € (0,00 %)     ALSTOM 17.050 € (-0,20 %)     GECINA 72.400 € (-0,21 %)     EDENRED 20.620 € (+1,53 %)     BOUYGUES 52.200 € (-0,53 %)     UNILEVER 48.705 € (-1,23 %)     VALEO 11.120 € (-1,20 %)     REXEL 36.750 € (-1,63 %)     ELIS 26.580 € (-0,97 %)     TKH GROUP 42.360 € (-0,33 %)     EURONEXT 146.600 € (-0,07 %)  
AXA
CS - FR0000120628 - Euronext Paris
42,420 €  17:38
-0,07 %
21/04/2026 19:15

AXA - Description of the Company’s share repurchase program

Paris, April 21, 2026

Description of the Company’s share repurchase program

Pursuant to Article 241-2 of the AMF General Regulations (Règlement Général de l’Autorité des marchés financiers), the purpose of the description below is to set out the objectives and terms of AXA’s (the “Company”) share repurchase program that will be submitted for shareholder approval at AXA’s Ordinary Shareholders’ Meeting to be held on April 30, 2026.

Date of the Shareholders’ Meeting convened to authorize the program:
April 30, 2026

Treasury shares held on March 31, 2026:

Number of treasury shares held by the CompanyHedging of free share plans and stock option plans granted to employeesCancellation
22,728,01933,722,228

Objectives of the Company’s share repurchase program:

Pursuant to the provisions of the European Commission Regulation n° 596/2014 of April 16, 2014, the Commission Delegated Regulation n° 2016/1052 of March 8, 2016 and in accordance with market practices accepted by the AMF, the objectives of the Company’s share repurchase program to be submitted to the shareholders for approval on April 30, 2026 are the following:

  1. a) (i) hedging stock option plans or other share allocations granted to some or all eligible employees or corporate officers of the Company and/or affiliated companies or economic interest groups as defined in Article L.225-180 of the French Commercial Code (Code de commerce), (ii) granting for free or assigning shares to some or all current or former employees, corporate officers and general insurance agents enrolled in any employee savings plan sponsored by the Company or the AXA Group pursuant to applicable laws and regulations, in particular Articles L.3332-1 et seq. of the French Labor Code (Code du travail), or any foreign law share plan, (iii) granting free shares to some or all employees and/or corporate officers of the Company, notably in accordance with the provisions of Articles L.225-197-1 et seq. and L.22-10-59 et seq. of the French Commercial Code and/or its affiliated companies or economic interest groups as defined in Article L.225-197-2 of the French Commercial Code, or more generally, in accordance with and on the terms and conditions allowed by laws and regulations;
  2. b) optimizing the liquidity of AXA ordinary shares through a liquidity contract entered into with an investment service provider, in accordance with a market practice accepted by the AMF, provided that, for the calculation of the 10% limit, the number of such repurchased shares shall be equal to the purchased shares minus the number of shares resold throughout the term of this authorization;
  3. c) holding and later delivering said shares as payment or consideration in the context of external growth transactions, mergers, spin-offs or contributions;
  4. d) delivering said shares upon exercise of the rights attached to securities corresponding to debt instruments giving, immediate or future right to the Company’s share capital through repayment, conversion, exchange, presentation of a warrant or in any other manner;
  5. e) cancelling them, in whole or in part pursuant to an authorization granted by an Extraordinary Shareholders’ Meeting; or
  6. f) more generally, performing all operations relating to hedging operations or any other operation which are permitted, or which may subsequently be permitted, by the laws and regulations in force.

Maximum percentage of share capital and maximum number of shares that may be repurchased by the Company and maximum purchase price:

Share repurchase program submitted to
The shareholder’s approval on April 30, 2026
Type of securitiesMaximum % of share capitalMaximum number of shares1Maximum purchase price (per share)
Ordinary shares10% of the total number of shares comprising the share capital2209,062,187€50 (excluding charges)3

Term of the repurchase program

18 months from the date of the Shareholders’ Meeting to be held on April 30, 2026, subject to approval of the program by the shareholders.

* * *

ABOUT THE AXA GROUP

The AXA Group is a worldwide leader in insurance, with 156,000 employees serving 92 million clients in 52 countries. In 2025, IFRS17 revenues amounted to Euro 115.5 billion and IFRS17 underlying earnings to Euro 8.4 billion.

The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 – Bloomberg: CS FP – Reuters: AXAF.PA). AXA’s American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY.

The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD.

It is a founding member of the UN Environment Programme’s Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment.

This press release and the regulated information made public by AXA pursuant to article L. 451-1-2 of the French Monetary and Financial Code and articles 222-1 et seq. of the Autorité des marchés financiers’ General Regulation are available on the AXA Group website (axa.com).

THIS PRESS RELEASE IS AVAILABLE ON THE AXA GROUP WEBSITE axa.com

FOR MORE INFORMATION:

Investor Relations: +33.1.40.75.48.42
investor.relations@axa.com

Individual Shareholder Relations:
+33.1.40.75.48.43

Media Relations: +33.1.40.75.46.74
ziad.gebran@axa.com
ahlem.girard@axa.com
sylwia.tulak@axa.com

Corporate Responsibility strategy:
axa.com/en/about-us/strategy-commitments

SRI ratings:
axa.com/en/investor/sri-ratings-ethical-indexes

Notes

  1. This number represents the theoretical maximum number of shares that may be purchased by the Company, calculated on the basis of the Company’s statutory share capital recorded on February 25, 2026, i.e., €4,787,524,091.46 divided into 2,090,621,874 shares. Based on the number of treasury shares already held by the Company as of March 31, 2026, AXA could purchase up to 152,611,940 of its own shares.
  2. This maximum percentage of the total number of shares comprising the share capital will be 5% if the shares are purchased by the Company with the purpose of being held for subsequent payment or tender in the context of a merger, spin-off or contribution.
  3. The theoretical maximum amount that the Company could allocate for the acquisition of ordinary shares in the context of the current share repurchase program would be €10,453,109,350 which represents 209,062,187 ordinary shares acquired at the €50 maximum price per share (excluding charges) as outlined above and calculated on the basis of the Company’s statutory share capital recorded on February 25, 2026.

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière